6.37
-0.405(-5.98%)
Currency In USD
| Previous Close | 6.77 |
| Open | 6.76 |
| Day High | 6.96 |
| Day Low | 6.1 |
| 52-Week High | 597.6 |
| 52-Week Low | 3.08 |
| Volume | 219,909 |
| Average Volume | 1.81M |
| Market Cap | 10.61M |
| PE | 0 |
| EPS | 7,123.5 |
| Moving Average 50 Days | 8.24 |
| Moving Average 200 Days | 44.63 |
| Change | -0.41 |
If you invested $1000 in Cyclacel Pharmaceuticals, Inc. (CYCC) 10 years ago, it would be worth $0.01 as of September 30, 2025 at a share price of $6.365. Whereas If you bought $1000 worth of Cyclacel Pharmaceuticals, Inc. (CYCC) shares 5 years ago, it would be worth $0.48 as of September 30, 2025 at a share price of $6.365.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.
GlobeNewswire Inc.
Sep 12, 2025 10:00 AM GMT
KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the “Company”), a company engaged in diversified industries, today announced that it has closed the previously
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
GlobeNewswire Inc.
Aug 04, 2025 10:50 PM GMT
- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Compa
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
GlobeNewswire Inc.
Jul 16, 2025 1:00 PM GMT
Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price